|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0002 USD | -98.33% |
|
-98.52% | -99.84% |
| Apr. 10 | Sorrento Therapeutics, Inc. Emerged from Bankruptcy | CI |
| Mar. 15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
Sorrento Therapeutics, Inc., emerged from its Chapter 11 bankruptcy as its plan of reorganization became effective on April 10, 2024. Sorrento Therapeutics, Inc., had filed its plan in the Court on November 30, 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -99.84% | 109K | |
| +9.42% | 115B | |
| +11.84% | 106B | |
| -2.53% | 21.96B | |
| -14.15% | 21.87B | |
| -5.29% | 19.21B | |
| -4.16% | 18.08B | |
| -38.29% | 17.71B | |
| +7.99% | 14.32B | |
| +36.24% | 12.42B |
SORRENTO THERAPEUTICS, INC. 
